The authors reply
- PMID: 39007584
- DOI: 10.1097/CCM.0000000000006326
The authors reply
Conflict of interest statement
Dr. Taylor’s institution received funding from the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality; she received funding from Abionyx biotech; and she received support for article research from the NIH. Dr. Chou has disclosed that he does not have any potential conflicts of interest.
References
-
- Taylor SP, Kowalkowski MA, Skewes S, et al.: Real-world implications of updated surviving sepsis campaign antibiotic timing recommendations. Crit Care Med. 2024 Feb 22. [online ahead of print]
-
- Oud L: Risk- and probability-based timing of antibiotics and outcomes of patients with suspected serious infection: Did the COVID-19 pandemic affect processes and outcomes? Crit Care Med. 2024; 52:e435–e436
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources